Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis, Biliary | 7 | 2023 | 105 | 1.220 |
Why?
|
Liver Cirrhosis | 11 | 2022 | 1930 | 1.080 |
Why?
|
Hepatitis, Autoimmune | 6 | 2023 | 172 | 1.020 |
Why?
|
Ammonia | 2 | 2016 | 236 | 0.960 |
Why?
|
Ceftriaxone | 1 | 2019 | 175 | 0.600 |
Why?
|
Hepatic Encephalopathy | 2 | 2015 | 144 | 0.560 |
Why?
|
Peritonitis | 1 | 2019 | 369 | 0.550 |
Why?
|
Stomach Diseases | 2 | 2015 | 133 | 0.540 |
Why?
|
Transaminases | 1 | 2017 | 196 | 0.540 |
Why?
|
Quinolones | 1 | 2019 | 377 | 0.500 |
Why?
|
Gastric Antral Vascular Ectasia | 1 | 2014 | 6 | 0.480 |
Why?
|
Hyperammonemia | 1 | 2015 | 76 | 0.460 |
Why?
|
Nucleosides | 1 | 2014 | 131 | 0.450 |
Why?
|
Liver Transplantation | 4 | 2023 | 2325 | 0.430 |
Why?
|
Hypertension, Portal | 1 | 2014 | 226 | 0.390 |
Why?
|
Nucleotides | 1 | 2014 | 450 | 0.390 |
Why?
|
Gastroenterology | 2 | 2016 | 571 | 0.390 |
Why?
|
Drug Resistance, Bacterial | 1 | 2019 | 1055 | 0.380 |
Why?
|
Gastrointestinal Hemorrhage | 5 | 2017 | 1110 | 0.380 |
Why?
|
Enteral Nutrition | 1 | 2017 | 785 | 0.370 |
Why?
|
Bacterial Infections | 1 | 2019 | 1401 | 0.360 |
Why?
|
Cholangitis, Sclerosing | 3 | 2023 | 177 | 0.350 |
Why?
|
Cholangitis | 2 | 2023 | 113 | 0.350 |
Why?
|
Hepatitis B, Chronic | 1 | 2014 | 403 | 0.350 |
Why?
|
Receptors, Aryl Hydrocarbon | 2 | 2023 | 220 | 0.340 |
Why?
|
Patient Admission | 2 | 2016 | 1372 | 0.330 |
Why?
|
Hepacivirus | 2 | 2015 | 1333 | 0.310 |
Why?
|
End Stage Liver Disease | 2 | 2022 | 352 | 0.300 |
Why?
|
Anorexia Nervosa | 1 | 2017 | 1361 | 0.300 |
Why?
|
Colonoscopy | 1 | 2016 | 1388 | 0.290 |
Why?
|
Muscle Cramp | 2 | 2024 | 34 | 0.290 |
Why?
|
Hepatitis C | 2 | 2015 | 1579 | 0.290 |
Why?
|
Liver Diseases | 3 | 2022 | 1296 | 0.270 |
Why?
|
Ursodeoxycholic Acid | 2 | 2023 | 79 | 0.270 |
Why?
|
Liver Function Tests | 2 | 2018 | 523 | 0.270 |
Why?
|
Antiviral Agents | 2 | 2018 | 3056 | 0.260 |
Why?
|
Organ Transplantation | 1 | 2015 | 1150 | 0.240 |
Why?
|
Muscle Stretching Exercises | 1 | 2024 | 36 | 0.230 |
Why?
|
Hepatorenal Syndrome | 1 | 2023 | 76 | 0.200 |
Why?
|
Meditation | 1 | 2024 | 251 | 0.190 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7403 | 0.180 |
Why?
|
Withholding Treatment | 2 | 2014 | 610 | 0.180 |
Why?
|
Clinical Competence | 1 | 2016 | 4775 | 0.170 |
Why?
|
Cholestasis | 1 | 2023 | 377 | 0.170 |
Why?
|
Waiting Lists | 3 | 2023 | 762 | 0.170 |
Why?
|
Vasoconstrictor Agents | 1 | 2023 | 651 | 0.160 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2011 | 2292 | 0.160 |
Why?
|
Th17 Cells | 2 | 2023 | 785 | 0.150 |
Why?
|
Apyrase | 1 | 2020 | 373 | 0.150 |
Why?
|
Refeeding Syndrome | 1 | 2017 | 16 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 388 | 0.140 |
Why?
|
Balloon Occlusion | 1 | 2017 | 125 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6852 | 0.130 |
Why?
|
Graft Survival | 2 | 2023 | 3794 | 0.130 |
Why?
|
Liver | 3 | 2022 | 7502 | 0.130 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4313 | 0.130 |
Why?
|
Mass Screening | 1 | 2011 | 5427 | 0.130 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 208 | 0.120 |
Why?
|
Hepatitis | 1 | 2017 | 229 | 0.120 |
Why?
|
Venous Pressure | 1 | 2014 | 57 | 0.120 |
Why?
|
Esophageal Diseases | 1 | 2015 | 168 | 0.120 |
Why?
|
Portal Pressure | 1 | 2014 | 60 | 0.120 |
Why?
|
Acetaminophen | 1 | 2018 | 552 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12096 | 0.120 |
Why?
|
Hepatitis B e Antigens | 1 | 2014 | 133 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1136 | 0.120 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2014 | 113 | 0.110 |
Why?
|
Cholagogues and Choleretics | 2 | 2023 | 37 | 0.110 |
Why?
|
Recurrence | 5 | 2022 | 8426 | 0.110 |
Why?
|
Time Factors | 5 | 2023 | 39872 | 0.110 |
Why?
|
Guanine | 1 | 2014 | 278 | 0.110 |
Why?
|
Lamivudine | 1 | 2014 | 362 | 0.110 |
Why?
|
Humans | 37 | 2024 | 758406 | 0.100 |
Why?
|
Drug Monitoring | 2 | 2018 | 960 | 0.100 |
Why?
|
Middle Aged | 18 | 2024 | 219568 | 0.100 |
Why?
|
Laparotomy | 1 | 2014 | 465 | 0.100 |
Why?
|
Fatigue | 1 | 2019 | 1542 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2023 | 80168 | 0.090 |
Why?
|
Up-Regulation | 2 | 2020 | 4113 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15785 | 0.090 |
Why?
|
Colonic Polyps | 1 | 2016 | 551 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 505 | 0.090 |
Why?
|
Malnutrition | 1 | 2017 | 639 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2018 | 1031 | 0.090 |
Why?
|
Female | 20 | 2024 | 390323 | 0.090 |
Why?
|
Treatment Outcome | 7 | 2024 | 64378 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7818 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3425 | 0.080 |
Why?
|
Gastrointestinal Agents | 1 | 2014 | 508 | 0.080 |
Why?
|
Aged | 12 | 2024 | 168218 | 0.080 |
Why?
|
Male | 19 | 2024 | 358747 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1386 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 878 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1436 | 0.080 |
Why?
|
Adult | 12 | 2023 | 219935 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3858 | 0.080 |
Why?
|
Adenine | 1 | 2014 | 975 | 0.080 |
Why?
|
Risk Factors | 8 | 2023 | 73809 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 820 | 0.080 |
Why?
|
Boston | 2 | 2019 | 9304 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2244 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 867 | 0.070 |
Why?
|
Length of Stay | 2 | 2019 | 6439 | 0.070 |
Why?
|
Intraoperative Complications | 1 | 2014 | 1184 | 0.070 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1115 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 12440 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3071 | 0.070 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4809 | 0.070 |
Why?
|
Tissue Donors | 1 | 2015 | 2311 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6821 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13285 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6493 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2751 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1292 | 0.060 |
Why?
|
Aspartate Aminotransferases | 2 | 2018 | 415 | 0.060 |
Why?
|
Prognosis | 7 | 2022 | 29557 | 0.060 |
Why?
|
Adenoma | 1 | 2016 | 2148 | 0.060 |
Why?
|
Patient Readmission | 2 | 2015 | 3261 | 0.060 |
Why?
|
Uridine | 1 | 2023 | 142 | 0.050 |
Why?
|
Bezafibrate | 1 | 2023 | 14 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2005 | 337 | 0.050 |
Why?
|
Hydrocarbons | 1 | 2023 | 105 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 139 | 0.050 |
Why?
|
Antipruritics | 1 | 2023 | 31 | 0.050 |
Why?
|
Lypressin | 1 | 2023 | 26 | 0.050 |
Why?
|
Anticoagulants | 2 | 2015 | 4777 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6768 | 0.050 |
Why?
|
Risk Assessment | 3 | 2019 | 23884 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12951 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2540 | 0.050 |
Why?
|
Vibration | 1 | 2022 | 327 | 0.040 |
Why?
|
Ascites | 1 | 2022 | 338 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2023 | 865 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2420 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2022 | 343 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3326 | 0.040 |
Why?
|
Pruritus | 1 | 2023 | 377 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2023 | 1825 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 12876 | 0.040 |
Why?
|
North America | 1 | 2023 | 1276 | 0.040 |
Why?
|
Prospective Studies | 4 | 2016 | 54137 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39059 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 855 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9160 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11593 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1892 | 0.040 |
Why?
|
Immunomodulation | 1 | 2020 | 545 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2513 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2018 | 604 | 0.030 |
Why?
|
Water | 1 | 2022 | 1402 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10652 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 370 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 41256 | 0.030 |
Why?
|
beta-Alanine | 1 | 2014 | 81 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1557 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10146 | 0.030 |
Why?
|
Acute Disease | 2 | 2017 | 7225 | 0.030 |
Why?
|
Oxygen | 1 | 2005 | 4191 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2014 | 512 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3258 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2005 | 3664 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2023 | 2980 | 0.030 |
Why?
|
Stroke | 1 | 2014 | 9694 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1044 | 0.030 |
Why?
|
Enoxaparin | 1 | 2014 | 392 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2017 | 5272 | 0.020 |
Why?
|
Morpholines | 1 | 2014 | 580 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2014 | 2262 | 0.020 |
Why?
|
Thiophenes | 1 | 2014 | 569 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4540 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2015 | 58683 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2014 | 855 | 0.020 |
Why?
|
Pyridones | 1 | 2014 | 784 | 0.020 |
Why?
|
Echocardiography | 1 | 2022 | 4962 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4158 | 0.020 |
Why?
|
Head | 1 | 2014 | 921 | 0.020 |
Why?
|
Thromboembolism | 1 | 2014 | 996 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7980 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5460 | 0.020 |
Why?
|
Emergencies | 1 | 2014 | 1209 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 640 | 0.020 |
Why?
|
Young Adult | 1 | 2014 | 58808 | 0.020 |
Why?
|
Endoscopy | 1 | 2017 | 1834 | 0.020 |
Why?
|
Heparin | 1 | 2014 | 1632 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2011 | 664 | 0.020 |
Why?
|
Warfarin | 1 | 2014 | 1482 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 18940 | 0.010 |
Why?
|
Lung Diseases | 1 | 2014 | 1910 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1808 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 1988 | 0.010 |
Why?
|
Cause of Death | 1 | 2014 | 3675 | 0.010 |
Why?
|
Bacterial Adhesion | 1 | 2005 | 306 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7985 | 0.010 |
Why?
|
Triglycerides | 1 | 2011 | 2451 | 0.010 |
Why?
|
United States | 2 | 2023 | 72136 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13276 | 0.010 |
Why?
|
RNA, Viral | 1 | 2011 | 2836 | 0.010 |
Why?
|
Patient Discharge | 1 | 2015 | 3433 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13468 | 0.010 |
Why?
|
Cell Polarity | 1 | 2005 | 638 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2374 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8823 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8553 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12721 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14490 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23342 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16534 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22029 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81101 | 0.010 |
Why?
|
Coronary Disease | 1 | 2011 | 5917 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21272 | 0.010 |
Why?
|
Animals | 1 | 2023 | 167768 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20500 | 0.010 |
Why?
|
Concepts
(213)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_